Jan 4, 2012

Don't extend price control beyond 348 drug list: Pfizer

Don't extend price control beyond 348 drug list: Pfizer
The world's largest drug-maker, Pfizer, today said the industry supports the government's initiative to bring 348 drugs in the National List of Essential Medicines (NLEM) under price control, but the ambit should not be extended further.

Read More - Don't extend price control beyond 348 drug list: Pfizer

Categories:

0 comments: